Apogee Therapeutics Inc. (APGE)

Schlusskurs vom Vortag:

$52.22

Offen:

$51.33

24-Stunden-Volumen:

177.64K

Marktkapitalisierung:

$2.89B

Einnahmen:

-

Nettoeinkommen (Verlust:

$-71.91M

KGV:

-

EPS:

-

Netto-Cashflow:

-

1W Leistung:

+0.69%

1M Leistung:

-6.10%

6M Leistung:

+216.42%

1J Leistung:

+0.00%

1-Tages-Spanne:

$49.57

$52.23

52-Wochen-Spanne:

$14.19

$72.29

Apogee Therapeutics Inc. Stock (APGE) Company Profile

Firmenname

Apogee Therapeutics Inc.

Sektor

Healthcare (1217)

Branche

Biotechnology (697)

Telefon

650-394-5230

Adresse

221 Crescent Street, Building 17 Suite 102b, Waltham

Mitarbeiter

0

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

APGE's Discussions on Twitter

Apogee Therapeutics Inc. Stock (APGE) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-12-20	Eingeleitet	BTIG Research	Buy
2023-08-08	Eingeleitet	Guggenheim	Buy
2023-08-08	Eingeleitet	Jefferies	Buy
2023-08-08	Eingeleitet	Stifel	Buy
2023-08-08	Eingeleitet	TD Cowen	Outperform
2023-08-08	Eingeleitet	Wedbush	Outperform

Alle ansehen

Apogee Therapeutics Inc. Aktie (APGE) Neueste Nachrichten

Apogee Therapeutics to Participate at the 2024 Bank of America Healthcare Conference

GlobeNewswire Inc.

Apogee (APGE) Stock Rallies 95.6% in a Month: Here's Why

Zacks Investment Research

Apogee Therapeutics Announces First Participants Dosed in Phase 1 Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) and Other Inflammatory Diseases

GlobeNewswire Inc.

Top 3 Health Care Stocks That Are Ticking Portfolio Bombs

Benzinga

Apogee Therapeutics, Inc. Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $483 Million

GlobeNewswire Inc.

Apogee Therapeutics, Inc. Announces Pricing of Upsized $420 Million Underwritten Public Offering

GlobeNewswire Inc.

Finanzdaten der Apogee Therapeutics Inc.-Aktie (APGE)

Apogee Therapeutics Inc. (APGE) Nettogewinn 2024

Apogee Therapeutics Inc. (APGE) Gewinn je Aktie 2024

Apogee Therapeutics Inc.-Aktie (APGE) Insiderhandel